Marcus Spann

634 total citations
18 papers, 504 citations indexed

About

Marcus Spann is a scholar working on Pharmacology, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, Marcus Spann has authored 18 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 3 papers in Public Health, Environmental and Occupational Health and 3 papers in Immunology. Recurrent topics in Marcus Spann's work include Treatment of Major Depression (3 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers) and Platelet Disorders and Treatments (2 papers). Marcus Spann is often cited by papers focused on Treatment of Major Depression (3 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers) and Platelet Disorders and Treatments (2 papers). Marcus Spann collaborates with scholars based in United States, United Kingdom and Netherlands. Marcus Spann's co-authors include Catia Sternini, Duane E. Keith, Antón Barreiro‐Iglesias, Nicholas C. Brecha, Mark von Zastrow, Nigel W. Bunnett, J. Erickson, Susan Ball, David Bakish and James M. Russell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neurology and Psychological Medicine.

In The Last Decade

Marcus Spann

12 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcus Spann United States 8 282 262 89 82 80 18 504
Elisa De Grandis Italy 15 69 0.2× 153 0.6× 36 0.4× 45 0.5× 18 0.2× 46 578
Miri Carmel Israel 17 50 0.2× 286 1.1× 25 0.3× 50 0.6× 40 0.5× 25 618
Pierre‐Éric Juif Switzerland 15 63 0.2× 150 0.6× 82 0.9× 16 0.2× 60 0.8× 28 517
Steven James Wilson United Kingdom 10 69 0.2× 131 0.5× 98 1.1× 23 0.3× 75 0.9× 15 487
Jung-Eun Choi South Korea 14 68 0.2× 89 0.3× 45 0.5× 20 0.2× 78 1.0× 27 509
Catherine Curran United States 10 153 0.5× 148 0.6× 25 0.3× 39 0.5× 17 0.2× 34 582
Barbara Steinborn Poland 15 177 0.6× 164 0.6× 59 0.7× 32 0.4× 16 0.2× 74 650
David Shelley United States 10 94 0.3× 226 0.9× 108 1.2× 15 0.2× 49 0.6× 15 439
Marika Bianchi Italy 14 45 0.2× 172 0.7× 115 1.3× 15 0.2× 29 0.4× 17 535
Laurence Mignon United States 12 214 0.8× 368 1.4× 112 1.3× 54 0.7× 4 0.1× 28 860

Countries citing papers authored by Marcus Spann

Since Specialization
Citations

This map shows the geographic impact of Marcus Spann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus Spann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus Spann more than expected).

Fields of papers citing papers by Marcus Spann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus Spann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus Spann. The network helps show where Marcus Spann may publish in the future.

Co-authorship network of co-authors of Marcus Spann

This figure shows the co-authorship network connecting the top 25 collaborators of Marcus Spann. A scholar is included among the top collaborators of Marcus Spann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcus Spann. Marcus Spann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ran, Kathleen R., Samuel Berchi Kankam, Olaoluwa Ezekiel Dada, et al.. (2025). Perceived Barriers to a Neurosurgical Career for Medical Students and Unspecialized Residents Worldwide: A Systematic Literature Review. World Neurosurgery. 197. 123886–123886.
3.
Ahmad, Syed A., Andrew Kalra, Marcus Spann, et al.. (2025). Acute stroke in children with immune thrombocytopenia: A systematic review and meta‐analysis. British Journal of Haematology. 206(5). 1450–1457.
4.
Alshak, Mark N., et al.. (2025). Prostate cancer active surveillance in solid organ transplant: a matched study and literature review. British Journal of Urology. 136(3). 464–472.
5.
Spann, Marcus, et al.. (2024). Remote Delivery of Vestibular Rehabilitation for Vestibular Dysfunction: A Systematic Review. Otology & Neurotology. 45(6). 608–618.
6.
Kalra, Andrew, Arjun K. Menta, Syed A. Ahmad, et al.. (2024). Long-Term Neuropsychiatric, Neurocognitive, and Functional Outcomes of Patients Receiving ECMO. Neurology. 102(3). e208081–e208081. 8 indexed citations
7.
Afghani, Elham, Su Jin Lim, Salvador Rodriguez Franco, et al.. (2023). Predictive ability of pancreatic cyst fluid biomarkers: A systematic review and meta-analysis. Pancreatology. 23(7). 868–877. 41 indexed citations
8.
Kalra, Andrew, Syed A. Ahmad, Arjun K. Menta, et al.. (2023). A recommended preclinical extracorporeal cardiopulmonary resuscitation model for neurological outcomes: A scoping review. Resuscitation Plus. 15. 100424–100424.
10.
Spann, Marcus, et al.. (2023). The Mediator Complex Subunit 12 (MED-12) Gene and Uterine Fibroids: a Systematic Review. Reproductive Sciences. 31(2). 291–308. 5 indexed citations
11.
Cho, Sung‐Min, Chiara Robba, Michael N. Diringer, et al.. (2023). Optimal Design of Clinical Trials Involving Persons with Disorders of Consciousness. Neurocritical Care. 40(1). 74–80. 3 indexed citations
12.
Spann, Marcus, et al.. (2023). Biomarkers Assessing the Role of Cumulus Cells on IVF Outcomes: A Systematic Review. Journal of Assisted Reproduction and Genetics. 41(2). 253–275. 5 indexed citations
13.
Roehrborn, Claus G., et al.. (2014). Estrogen receptor beta agonist LY500307 fails to improve symptoms in men with enlarged prostate secondary to benign prostatic hypertrophy. Prostate Cancer and Prostatic Diseases. 18(1). 43–48. 31 indexed citations
14.
Kelin, Katarina, Michael Berk, Marcus Spann, et al.. (2010). Duloxetine 60 mg/day for the prevention of depressive recurrences:post hocanalyses from a recurrence prevention study. International Journal of Clinical Practice. 64(6). 719–726. 10 indexed citations
15.
Nicolini, Humberto, David Bakish, Héctor Dueñas, et al.. (2008). Improvement of psychic and somatic symptoms in adult patients with generalized anxiety disorder: examination from a duloxetine, venlafaxine extended-release and placebo-controlled trial. Psychological Medicine. 39(2). 267–276. 58 indexed citations
16.
Allgulander, Christer, D.J. Nutt, Michael J. Detke, et al.. (2008). A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder. Journal of Psychopharmacology. 22(4). 417–425. 34 indexed citations
17.
Sternini, Catia, Marcus Spann, Antón Barreiro‐Iglesias, et al.. (1996). Agonist-selective endocytosis of mu opioid receptor by neurons in vivo.. Proceedings of the National Academy of Sciences. 93(17). 9241–9246. 298 indexed citations
18.
Sternini, Catia, Marcus Spann, Roberto De Giorgio, et al.. (1995). CELLULAR LOCALIZATION OF THE MU OPIOID RECEPTOR IN THE RAT AND GUINEA PIG ENTERIC NERVOUS SYSTEM. 1(4). 762–765. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026